Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.

Company to host investor webcast and conference call on February 12 at 7 a.m. PT / 10 a.m. ET Investor webcast will feature the clinical validation data and review commercial launch timeline BRISBANE, ...

Margaret Lozovatsky, MD, FAMIA, has spent years helping health systems adopt digital tools designed to improve patient care. As a pediatric hospitalist, she has also seen what can go wrong. In one ...

There have been some interesting failures recently in Alzheimer’s trials. Two are notable because they’re aimed outside the usual amyloid zone. Novo Nordisk (NVO) recently reported that semaglutide ...

The second Trump administration has been defined by widespread cuts to federal spending, including at the National Institutes of Health (NIH). A new analysis reveals that the termination of NIH grants ...

Artificial intelligence-enabled medical devices with no clinical validation were more likely to be the subject of recalls, according to a study published in JAMA Health Forum. The study, published on ...

The adoption of the new “clinical obesity” definition alters prevalence estimates of obesity in many parts of the world compared with BMI-based definitions, new data suggested. In January 2025, a ...

A pair of CROs from opposite sides of the Atlantic Ocean are merging to form a global organization. Evestia Clinical and Atlantic Research Group are joining forces to bring clients expertise in ...

Back when I first wrote about Hyperlight, Microsoft’s minimal hypervisor, I speculated that it had a possible role as a WebAssembly-based alternative to serverless computing tools like Azure Functions ...

Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal DNA methylation measurements and comprehensive ...